Table 5 Comparison of curative effects between liver fibrosis subgroup and cirrhosis subgroup.

From: Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE

Subgroup

Before treatment LSM/kPa

After treatment LSM/kPa

Curative effects

P

Liver fibrosis subgroup

Control group (85 )

9.4 (8.3, 11.7)

7.3 (6.85, 9.4)

− 1.5 ( −2.15 , −0.09)

 < 0.0001

Observation group (86 )

9.55 (8.4, 11.5)

6.65 (5.4, 7.925)

−3 ( −3.85, −2.00)

 < 0.0001

P

0.8466

 < 0.0001

 < 0.0001

 

Liver cirrhosis subgroup

Control group (35 )

18.7 (18, 25.8)

18.3 (16.3 , 28.4)

− 1.5 (−2.2 , 1.1)

0.0975

Observation group (33)

19.9 (18, 26.1)

15.7 (13.1, 19.7)

−5.7 (−7.2, −4.1)

 < 0.0001

P

0.7047

 < 0.0001

 < 0.0001

 
Back to article page